Accounting for Tastes Florian VogtDavid L. B. SchwappachJohn F. P. Bridges Commentary 09 October 2012 Pages: 419 - 423
Cost Effectiveness of Preventive Interventions in Type 2 Diabetes Mellitus Sylvia M. C. VijgenMirjam HoogendoornTalitha L. Feenstra Review Article 09 October 2012 Pages: 425 - 441
Cost Effectiveness of Increasing the Dose Intensity of Chemotherapy with Granulocyte Colony-Stimulating Factor in Small-Cell Lung Cancer Laura BojkeMark SculpherDavid Girling Original Research Article 09 October 2012 Pages: 443 - 452
Encouraging Smokers to Quit Janneke KaperEdwin J. WagenaJohan L. Severens Original Research Article 09 October 2012 Pages: 453 - 464
Comprehensive Decision-Analytic Model and Bayesian Value-of-Information Analysis Cynthia P. IglesiasKarl Claxton Original Research Article 09 October 2012 Pages: 465 - 478
Economic Evaluation of Weekly Epoetin Alfa versus Biweekly Darbepoetin Alfa for Chemotherapy-Induced Anaemia Shelby D. ReedJasmina I. RadevaKevin A. Schulman Original Research Article 09 October 2012 Pages: 479 - 494
Letrozole Christopher DunnSusan J. Keam Adis Pharmacoeconomic Drug Evaluation 09 October 2012 Pages: 495 - 517
Cost Considerations in the Medical Management of Glaucoma in the US: Estimated Yearly Costs and Cost Effectiveness of Bimatoprost Compared with Other Medications Javier Soto Correspondence 09 October 2012 Pages: 519 - 520
The Authors’ Reply Lawrence D. GoldbergJohn G. Walt Correspondence 09 October 2012 Pages: 520 - 522